Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study
Nasopharyngeal swab specimen (NPS) molecular testing is considered the gold standard for SARS-CoV-2 detection. However, saliva is an attractive, noninvasive specimen alternative. The aim of the study was to evaluate the diagnostic accuracy of Advanta Dx SARS-CoV-2 RT-PCR saliva-based assay against p...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/11/10/1766 |
| _version_ | 1797514861737934848 |
|---|---|
| author | Sofia Balaska Dimitrios Pilalas Anna Takardaki Paraskevoula Koutra Eleftheria Parasidou Ioanna Gkeka Areti Tychala Georgios Meletis Barbara Fyntanidou Simeon Metallidis Efthymia Protonotariou Lemonia Skoura |
| author_facet | Sofia Balaska Dimitrios Pilalas Anna Takardaki Paraskevoula Koutra Eleftheria Parasidou Ioanna Gkeka Areti Tychala Georgios Meletis Barbara Fyntanidou Simeon Metallidis Efthymia Protonotariou Lemonia Skoura |
| author_sort | Sofia Balaska |
| collection | DOAJ |
| description | Nasopharyngeal swab specimen (NPS) molecular testing is considered the gold standard for SARS-CoV-2 detection. However, saliva is an attractive, noninvasive specimen alternative. The aim of the study was to evaluate the diagnostic accuracy of Advanta Dx SARS-CoV-2 RT-PCR saliva-based assay against paired NPS tested with either NeumoDx<sup>TM</sup> SARS-CoV-2 assay or Abbott Real Time SARS-CoV-2 assay as the reference method. We prospectively evaluated the method in two settings: a diagnostic outpatient and a healthcare worker screening convenience sample, collected in November–December 2020. SARS-CoV-2 was detected in 27.7% (61/220) of diagnostic samples and in 5% (10/200) of screening samples. Overall, saliva test in diagnostic samples had a sensitivity of 88.5% (77.8–95.3%) and specificity of 98.1% (94.6–99.6%); in screening samples, the sensitivity was 90% (55.5–99.7%) and specificity 100% (98.1–100%). Our data suggests that the Fluidigm Advanta Dx RT-PCR saliva-based assay may be a reliable diagnostic tool for COVID-19 diagnosis in symptomatic individuals and screening asymptomatic healthcare workers. |
| first_indexed | 2024-03-10T06:37:32Z |
| format | Article |
| id | doaj.art-6a898e86eef0449abb12143fc05da6c0 |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-10T06:37:32Z |
| publishDate | 2021-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-6a898e86eef0449abb12143fc05da6c02023-11-22T17:56:25ZengMDPI AGDiagnostics2075-44182021-09-011110176610.3390/diagnostics11101766Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy StudySofia Balaska0Dimitrios Pilalas1Anna Takardaki2Paraskevoula Koutra3Eleftheria Parasidou4Ioanna Gkeka5Areti Tychala6Georgios Meletis7Barbara Fyntanidou8Simeon Metallidis9Efthymia Protonotariou10Lemonia Skoura11Department of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceEmergency Department, AHEPA University Hospital, 54636 Thessaloniki, GreeceFirst Department of Internal Medicine, Infectious Diseases Division, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, Medical School, Aristotle University οf Thessaloniki, 54636 Thessaloniki, GreeceNasopharyngeal swab specimen (NPS) molecular testing is considered the gold standard for SARS-CoV-2 detection. However, saliva is an attractive, noninvasive specimen alternative. The aim of the study was to evaluate the diagnostic accuracy of Advanta Dx SARS-CoV-2 RT-PCR saliva-based assay against paired NPS tested with either NeumoDx<sup>TM</sup> SARS-CoV-2 assay or Abbott Real Time SARS-CoV-2 assay as the reference method. We prospectively evaluated the method in two settings: a diagnostic outpatient and a healthcare worker screening convenience sample, collected in November–December 2020. SARS-CoV-2 was detected in 27.7% (61/220) of diagnostic samples and in 5% (10/200) of screening samples. Overall, saliva test in diagnostic samples had a sensitivity of 88.5% (77.8–95.3%) and specificity of 98.1% (94.6–99.6%); in screening samples, the sensitivity was 90% (55.5–99.7%) and specificity 100% (98.1–100%). Our data suggests that the Fluidigm Advanta Dx RT-PCR saliva-based assay may be a reliable diagnostic tool for COVID-19 diagnosis in symptomatic individuals and screening asymptomatic healthcare workers.https://www.mdpi.com/2075-4418/11/10/1766COVID-19SARS-CoV-2salivaPCR |
| spellingShingle | Sofia Balaska Dimitrios Pilalas Anna Takardaki Paraskevoula Koutra Eleftheria Parasidou Ioanna Gkeka Areti Tychala Georgios Meletis Barbara Fyntanidou Simeon Metallidis Efthymia Protonotariou Lemonia Skoura Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study Diagnostics COVID-19 SARS-CoV-2 saliva PCR |
| title | Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study |
| title_full | Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study |
| title_fullStr | Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study |
| title_full_unstemmed | Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study |
| title_short | Evaluation of the Advanta Dx SARS-CoV-2 RT-PCR Assay, a High-Throughput Extraction-Free Diagnostic Test for the Detection of SARS-CoV-2 in Saliva: A Diagnostic Accuracy Study |
| title_sort | evaluation of the advanta dx sars cov 2 rt pcr assay a high throughput extraction free diagnostic test for the detection of sars cov 2 in saliva a diagnostic accuracy study |
| topic | COVID-19 SARS-CoV-2 saliva PCR |
| url | https://www.mdpi.com/2075-4418/11/10/1766 |
| work_keys_str_mv | AT sofiabalaska evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT dimitriospilalas evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT annatakardaki evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT paraskevoulakoutra evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT eleftheriaparasidou evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT ioannagkeka evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT aretitychala evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT georgiosmeletis evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT barbarafyntanidou evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT simeonmetallidis evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT efthymiaprotonotariou evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy AT lemoniaskoura evaluationoftheadvantadxsarscov2rtpcrassayahighthroughputextractionfreediagnostictestforthedetectionofsarscov2insalivaadiagnosticaccuracystudy |